Logo

Berkeley Lights Launches Two New Capabilities in the Opto Cell...

EMERYVILLE, Calif., Apr. 28, 2020 /PRNewswire-AsiaNet/-- -- The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights' platform develop cancer immunotherapies faster Today, Berkeley Lights, Inc., a leader in ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660